sedb.com Singapore's Experience - Economic Development with
Science and Technology 6 October 2010
Slide 2
2 Labour-intensive Skills-intensive Capital-intensive
Technology-intensive Innovator of new products & services
Innovation- Intensive Keep moving up ! 1960s 1970s 1980s 1990s
2000+
Slide 3
3 Singapores Economy GDP & Trade 2009 GDP (US$160 Billion)
2008 Trade (US$660 Billion)
Slide 4
4 Total Manufacturing Output (1986 2009) US$25 billion (1986)
ASIA $ CRISIS SARS CRISIS US$147 billion (2009) S$ mil
Slide 5
5 Total Manufacturing Output of 4 key clusters : US$115 billion
(2009) Chemicals Electronics Biomedical Sciences Precision Engrg S$
mil
Slide 6
6 Building the Data Storage Industry Cluster Cumulative Output
(1986-2009): US$178 billion S$ mil US$13 billion (1997) BUILD UP
PHASE GROWTH PHASE DECLINE PHASE US$1.6 billion (1986) US$5.5
billion (2009)
Slide 7
7 Cumulative Output (1986-2009): US$247 billion Building the
Semiconductor Industry Cluster BUILD UP PHASE GROWTH PHASE US$1.6
billion (1986) US$26.3 billion (2009) US$7.6 billion (1998) S$
mil
Slide 8
8 Building the Precision Engineering Industry Cluster
Cumulative Output (1986-2009): US$221 billion US$2.6 billion (1986)
BUILD UP PHASE GROWTH PHASE US$7 billion (1993)
Slide 9
9 Building The Chemicals Industry Cluster Cumulative Output
(1986 2009) - US$505 billion US$40 billion (2009) Official Opening
of Jurong Island 1995 Construction started on Jurong Island (US$22
billion) (US$12 billion) S$ mil
Slide 10
10 Singapore S$ 7 billion Reclamation Project S$38b of
investments 99 companies Over 15,000 employees Jurong Island: Heart
of Singapores Chemicals Hub
Slide 11
11 Building The Biomedical Sciences Industry Cluster Cumulative
Output (1986 2009) - US$120 billion US$4 billion (2000) BUILD UP
AND GROWTH PHASE US$14.7 billion (2009) S$ mil
Slide 12
12 Tuas Biomedical Manufacturing Park
Slide 13
13 Building up Biomedical Sciences A*STAR 2001
Slide 14
14 Vision Singapore The Biopolis of Asia An International
Biomedical Sciences Cluster Advancing Human Health Through the
Pursuit of Excellence in Research & Development, Manufacturing,
and Healthcare Delivery Basic, Translational & Clinical
Research Product & Process Development Pilot & Commercial
Manufacturing Regional HQ & Shared Services Healthcare
Delivery
Slide 15
15 How It All Started. A/Prof. Kong Hwai Loong Prof. John Wong
Prof. Tan Chorh Chuan 26thJune 2000
Slide 16
16 One North - Birds Eye View
Slide 17
CONFIDENTIAL 2010 IDA Singapore. All Rights Reserved. 17
Slide 18
18 Institute of Molecular & Cell Biology (IMCB) 1987
Singapore Bioimaging Consortium (SBIC) 2005 Singapore Stem Cell
Consortium (SSCC) 2006 Institute of Medical Biology (IMB) 2007
Singapore Institute for Clinical Sciences (SICS) 2006 Singapore
Immunology Network (SIgN) 2006 Genome Institute of Singapore (GIS)
2000 Bioprocessing Technology Institute (BTI) 2003 Institute of
Bioengineering & Nanotechnology (IBN) 2003 Bioinformatics
Institute (BII) 2001 Biopolis Shared Facilities (BSF) 2005
Biological Resource Centre (BRC) 2005 Experimental Therapeutics
Centre (ETC) 2008 Institute of High Performance Computing (IHPC)
1998 National Metrology Centre (NMC) 2008 Data Storage Institute
(DSI) 1992 Institute of Micro- electronics (IME) 1991 Institute for
Infocomm Research (I 2 R) 2002 Institute for Chemical &
Engineering Sciences (ICES) 2002 Institute of Materials Research
& Engineering (IMRE) 1996 Singapore Institute of Manufacturing
Technology (SIMTech) 1985 1987- 1989 2005 -2006 2007 -2008 2003
-2004 2001 -2002 200 0 1990- 1999 Singapore Consortium for Cohort
Studies (SCSC) 2006 Research Institutes A*STAR has more than 2,300
RSEs, of which more than 50% of them are international talent from
some 50 countries 60% PhD Biopolis Phase I (2003) Biopolis Phase II
(2006) Fusionopolis Phase I (2008)
Slide 19
19 Genomics & Proteomics Bioprocessing Chemical Synthesis
BIOTECHNOLGY & BIOLOGICS HEALTHCARE SERVICES & DELIVERY
Molecular & Cell Biology Bioengineering & Nanotechnology
Computational Biology Industry Sectors Bioimaging Cohort Studies
Stem cells Drug Discovery CLINICAL RESEARCH TRANSLATIONAL RESEARCH
PHARMACEUTICALS MEDICAL TECHNOLOGY Immunology Driving Basic
Research towards Clinical Outcomes
Slide 20
20 MEaT = Medical Enginering and Technology IMCB = Institute of
Molecular & Cell Biology GIS = Genome Institute of Singapore
BTI = Bioprocessing Technical Institute IBN = Institute of
Bioengineering and Nanotechnology BII = Bioinformatics Institute
IMB = Institute of Medical Biology SICS = Singapore Institute for
Clinical Sciences SBIC = Singapore Bioimaging Consortium SIgN =
Singapore Immunology Network SSCC = Singapore Stem Cell Consortium
STN = Singapore Tissue Network SCS = Singapore Cancer Syndicate
SCCS = Singapore Consortium of Cohort Studies DPF = Data Privacy
Framework BMS IF = Biomedical International Fellowship CSI =
Clincian Scientist Investigatorship IRBs = Institutional Review
Boards Mission-oriented BENCH INDUSTRY Co-investment, VC funding
RISC grants, infrastructure, tax breaks Pharma MEaTBiotech MOH
Singapore Clinical Trials IMCB, GIS, BTI IBN, BII, IMB Research
Institutes SBIC SSCC SIgN Biomarkers Research Consortia A*STAR /
BMRC BEDSIDE Clinical Research Programmes Focus, strategy Human
Capital Development, recruitment Infrastructure For Clinical Trials
Regulatory Framework IRBs DPF Office MBBS PhD / BMS IF / CSI awards
Translational / Investigational Medicine NMRC / HSA Clinical Trials
Overseas Clinical Trials STN SCS SCCS MTI Academic BENCH NUS, NTU
Drug discovery & devt Med tech / devices Biologics (cells /
vaccines) SICS
Slide 21
21 Portfolio approach to creating economic value Public Sector
R&D Novel Techniques Life Science Tools New Applications Devt
Niche Research Organizations Novel Technology Platforms New
manufacturing R&D centres/pilot plants/facility e.g. PharmBio
Mfg Technologies Novel Mfg Technology 1 LabAutomation's prestigious
Innovation AveNEW Spun out from IBN Identified as one of industry's
most innovative emerging laboratory technologies 1 Spun out from
SIgN Predicts and optimize peptide vaccines, reducing cycle
development time GSK Green Manufacturing endowment fund taps onto
R&D expertise in BTI, IBN, NUS, NTU, ICES Service providers
based on technology platforms developed, fill industrys in-house
capability gaps e.g. Roches partnership with Singapore institutions
(see next slide). R&D collaborations Novel Biomarker &
compound START-UPs based on new tools, reagents, assays etc.
Private public partnerships e.g. Clinical Imaging Research Centre:
NUS- A*STAR joint partnership with Siemens 21
Slide 22
22 Roche Hub for Translational Medicine Preclinical Research
Translational Research Basic Research Clinical Research Singapore
Inc R&D consortium (among public sector R&D players)
Singapore Inc R&D consortium (among public sector R&D
players) > Roches 1st Hub for Translational Medicine (TM)
worldwide > Investment of 100mil Swiss Francs > Focus on
expanding disease biology understanding to develop new personalised
treatment approaches > Single Master Collaboration Agreement
with Singapore Inc. entities, including A*STAR, NUS, NTU, NUH, NHG,
SingHealth > Joint Steering Committee between Roche &
Singapore institutes to define strategic direction & oversee
research projects Roche Hub for Translational Medicine in Singapore
Biomedical Research Council Collaboration with Industry model
Slide 23
23 Fusionopolis Phase 1 Facilities Fitness Gym & Pool
Retail and F&B Podium Shared Conference Rooms one-north MRT
Station Business and Research Space Skybridges and Sky Gardens
Serviced Work-Live Apartments 500-seat Experimental Performance
Theatre
Slide 24
24 Focus Medium to long term industry- oriented R&D Build,
strengthen and anchor industrial R&D capability Develop Human,
Intellectual, Industrial Capital To capture economic value through
the exploitation of intellectual & human capital derived from
basic & applied research Basic (directed) Applied Extramural
Programs Support thematic capabilities Leverage on external
expertise Industry Engagement Research collaboration with MNCs and
SMEs Technology Licensing Push out Leverage
CommercializationBlue-sky Confidential Not for Circulation Science
and Engineering Research Council (SERC)
Slide 25
25 Science and Engineering Research Council ELECTRONICS
CHEMICALS Microelectronics Data Storage Info-Comm Sciences Chemical
Sciences Materials Sciences Manufacturing Technology Industry
Sectors ELECTRONICS Semiconductors Storage & Peripherals
Advanced Display Electronic Components Electronic Modules IME DSI
CHEMICALS Petroleum/Petrochemicals Performance Materials Bio &
Consumer Chemistry Specialty Chemicals Process Engineering * IMRE
ICES INFOCOMM Devices Digital Content & Media Software &
Computing Communications I2RI2R ENGINEERING * SIMTech IHPC
Machinery & Systems Precision Modules Aerospace Precision
Components Marine & Offshore Automotive Computational Sciences
Metrology History | KBE | Biomed | S&E | Talent | Enterprise
Alignment of SERC RIs to meet Industry Needs
Slide 26
26 ELECTRONICS INFOCOMM ENGINEERING CHEMICALS Machinery &
Systems Precision Modules Aerospace Precision Components Offshore
Engrg Petroleum/Petrochemicals Performance Materials Bio &
Consumer Chemistry Specialty Chemicals Process Engineering
MicroElectronics Data Storage Info-Comm Sciences Chemical Sciences
Materials Sciences Manufacturing Technology Devices Digital Content
& Media Software & Computing Communications Semiconductors
Storage & Peripherals Advanced Display Electronic Components
Electronic Modules Home 2015 Ultra wide Band Polymer Elec.
Photonics Nano-elect. Sensors Mfg Systems Imaging Human-factor
Engineering Energy Synthetic Chemistry Nanotechnology Human-machine
interface Arrayed sensor networks Developing New Competencies
Computational Sciences Metrology
Slide 27
27 Human Capital Catch a few Whales !
Slide 28
28 Prof David Townsend Head of PET and SPECT Group, SBIC Dr
Stephen Cohen Acting Exec Dir, IMCB Attracting International
Scientific Talent Dr Edison Liu Exec Dir, GIS Dr Davor Solter PI,
IMB Sir David Lane Chief Scientist Dr Birgitte Lane Exec Dir, IMB
Dr Phil Ingham Dy Dir, IMCB Dr Jean Paul Thiery Dy Dir, IMCB Dr
Edward Holmes Executive Dy Chmn (TCSG), BMRC & Chmn, NMRC Dr
Judith Swain Exec Dir, SICS Dr Philippe Kourilsky Chairman, SIgN
Prof Peter Gluckman PI, SICS Sir George Radda Chmn, BMRC Dr Jackie
Ying Exec Dir, IBN Dr Alan Colman Exec Dir, SSCC Dr Dale Purves
Exec Dir, NRP Dr Frank Eisenhaber Director, BII Prof Paola
Castagnoli Scientific Dir, SIgN Prof Charles Zukoski Chmn, SERC Dr
Sydney Brenner Scientific Adviser, A*STAR Dr Keith Carpenter Exec
Dir, ICES Prof Dim-Lee Kwong Exec Dir, IME Prof Stephen Quake
Consultant Dr David Srolovitz Exec Dir, IHPC Dr Alex Matter
Director, ETC Dr Pantelis Alexopoulis, Exec Dir, DSI
Slide 29
29 Partnering with Industry Attracting and Growing R&D
Slide 30
30 Human Capital Train 1,000 PhD Guppies Guppy 0.03 meters
32 MIT Physics (Malaysia) Human Capital: International Guppies
Stanford Chemical Engineering (Shanghai) MIT Bio Engineering (Hong
Kong) Stanford Computer Science (India) MIT Chemical Engineering
(Vietnam)
Slide 33
33 Human Capital: Singapore Guppies Harvard Stem cells Post-Doc
Stanford Comput er Science, PhD Carnegi e Mellon Comput er Science,
BSc Stanford Developmental Biology PhD Cambridge Natural Science
Biology BSc Cambridge, London Medicine/PhD Stanford Genetics PhD
Imperial College London Cancer Biology PhD NUS Biomedical Sciences
PhD NTU Biological Sciences BSc
Slide 34
34 Immediate Responses to Overcome Crisis First-ever Use of
National Reserves (S$) Saving Jobs Enhancing Credit to Businesses
Build for the Future Business Upgrading Initiative for Long-term
Development Package to upgrade enterprise capabilities Economic
Strategies Committee (ESC) to chart future path for the economy
Action Taken 2009 Recession
Slide 35
35 Objective & Structure of Economic Strategies Committee
(ESC) Objective of ESC: Growing Singapores future as a leading
global city in the heart of Asia and ASEAN 1. Seizing Growth
Opportunities 6. Fostering Inclusive Growth 2. Developing A Vibrant
SME Sector & Globally Competitive Local Companies 3. Attracting
and Rooting MNCs & foreign SMEs 5. Making Singapore a leading
Global City 4. Growing Knowledge Capital HIGH PRODUCTIVITY STRONG
CAPABILITIES Corporate Resilience & Depth Human & Knowledge
Capital SUSTAINED AND INCLUSIVE GROWTH 7. Ensuring Energy
Resilience and Sustainable Growth 8. Maximising Value from Land as
a Scarce Resource Resource Optimisation
Slide 36
36 Key Development Strategies
Slide 37
37 Research Performers (1) Sustaining Knowledge Creation
Vibrant Centre for knowledge creation, innovation and
commercialisation for higher productivity-based growth Public e.g.
A*STAR RIs IHLs e.g. Universities, RCEs, CREATE, Duke-NUS GMS
Hospitals e.g. Singhealth, NHG Corp Labs Innovation Capital
Enterprises MNC/ GCC Local Enterprise Start-up Integrating for
Impact e.g. one-to-one collaborations, consortia, system-level
integration Gearing for Growth e.g. teaming local enterprises up
with MNCs through consortia, COI, outreach activities Seeding for
Surprises e.g. encouraging entrepreneurship, use-driven platforms,
commercialising IP (2) Growing Innovation Capital (3) Attracting
and Developing Talent in RIE (4) Funding (GERD - 3.5% of GDP by
2015) Singapores Economic Strategies Committee
Slide 38
38 Source: R&D Survey 2000-2008 R&D Spending as % of
GDP Science & Technology Plan 2010 2006-2010) S$13.9 billion
Science & Technology Plan 2005 (2001-2005) S$6 billion National
Science & Technology Plan (1996-2000) S$4 billion National
Technology Plan (1991-1995) S$2 billion 5-year Science &
Technology Plan Current target: to reach 3% GERD/GDP by 2010
Research, Innovation & Enterprise 2015 (2011-2015) S$ 16.1
billion Target of 3.5% GERD/GDP by 2015 2.8% Governments Commitment
to R&D
Slide 39
39 Singapore Economy as a Dynamic Pyramid Agency for Science,
Technology & Research - Generating Know-How - Attracting Whales
- Nurturing Guppies IE Singapore - Expanding Overseas Market Access
Economic Development Board Economic Development Board - Attracting
Foreign Direct Investments Small & Medium Enterprises ~ 30,000
Micro-Enterprises ~ 110,000 Global & Large Companies ~ 1,400
SPRING - Nurturing and Growing Enterprises - $1m - $100m JTC
Industrial Land & Space
Slide 40
40 YES! Schools Total: 31 schools supported, benefiting 6,000
students YES! Start-Ups Total: 41 start-ups SPRING SEEDS
Co-investment for start-ups Total: 173 start-ups Incubator
Development Programme Total: 10 incubators & venture
accelerators Proof of Concept/ Commercialisation Idea Generation Go
to Market Promising SMEs Seeding & Nurturing Innovative
Start-ups Key Initiatives Technology Enterprise Commercialisation
Scheme (TECS) Support Proof-of-Concept & Proof-of-Value
projects Total : 54 projects
Slide 41
41 Access to Innovation & Technology Encourage SMEs to
enhance or develop new product / process To support projects or
procure services from the various approved knowledge institutions
(launched Mar 09) Innovation Voucher Scheme (IVS) Approved Centres
of Innovation: 41
Slide 42
42 Building Technology Infrastructure Centres of Innovation
(COIs) One-stop centres offering technology consultancy and advice
Enviro & Water Tech COI @ Ngee Ann Polytechnic (launched Jul
08) Food Innovation & Resource Centre @ Spore Polytechnic
(launched May 07) Precision Engrg COI @ A*STAR SIMTECH (launched
May 08) Electronics COI @ Nanyang Polytechnic (launched on Jan 09)
Marine & Offshore Tech COI @ Ngee Ann Polytechnic (launched Oct
07) Centres of Innovation 42
44 Technology Innovation Programme (TIP) Upgrading Technology
Innovation in SMEs TECHNOLOGY INNOVATION IN SMES Catalyse
Technology Projects Promote technology awareness to SMEs in key
industries Facilitate & support technology projects by SMEs
Develop Technology Infrastructure Set up 5 Centres of Innovation
for key industry sectors Develop network of technology resources
Build Technology Innovation Capabilities Work with A*STARs T-Up
programme Second local / overseas experts & talent to SMEs Set
up technology talent database 44
Slide 45
45 Incubator Development Programme (IDP) Seeding &
Nurturing Innovative Start-ups iAxil Business Incubator NUS
Enterprise IncubatorNTU NanoFrontier Parco Fashion Incubator 5
incubators & 5 venture accelerators supported To increase ISUs
access to - Finance - Overseas Markets - Mentors & Experts -
Tech facilities Expected to nurture 330 startups over 3 years
45
Slide 46
46 Intellectual Property Management Programme Building
Enterprise Capabilities Phase II Implementation of recommendations
eg: IP Audit IP Education and Training IP Intelligence and Research
IP Portfolio Management IP Strategy IP Valuation IP Licensing Phase
I IPM Diagnostic tool to assess IP deployment and IPM systems
Provide strategic options and recommendations Phase II IPM
Capability Development Projects 46 Phase I SCOPE IP
